Acadian Asset Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
– Sell
-58
Closed -$7K – 1583
2016
Q4
$7K Buy
58
+5
+9% +$554 ﹤0.01% 1472
2016
Q3
$6K Sell
53
-4,262
-99% -$491K ﹤0.01% 1286
2016
Q2
$535K Buy
+4,315
New +$521K ﹤0.01% 754
2015
Q2
– Sell
-41
Closed -$4K – 1373
2015
Q1
$4K Sell
41
-35
-46% -$3.73K ﹤0.01% 1301
2014
Q4
$9K Buy
76
+41
+117% +$5.39K ﹤0.01% 1147
2014
Q3
$5K Buy
+35
New +$5.4K ﹤0.01% 934

Other funds holding CLB

Acadian Asset Management's CLB Position: Q1 2017 in Review

Acadian Asset Management sold out of Core Laboratories (CLB) in Q1 2017, closing a stake of 58 shares — an estimated $7K sold.

Acadian Asset Management first reported a position in CLB in Q3 2014 and held it in 6 quarters. The position peaked at $535K in Q2 2016. 360 funds tracked by Wall St. Rank hold CLB as of Q1 2017.

  • Acadian Asset Management reported no remaining Core Laboratories position as of Q1 2017 after selling out during the quarter.
  • Acadian Asset Management sold 58 Core Laboratories shares in Q1 2017, an estimated $7K.
  • Acadian Asset Management first reported a position in Core Laboratories in Q3 2014 and held it in 6 quarters.
  • Acadian Asset Management's Core Laboratories position peaked at $535K in Q2 2016.
  • 360 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2017.

Based on Acadian Asset Management's 13F filing for Q1 2017, filed 25 Apr 2017.